Evidence map›Paper›PMID 33821990›Full record

ArticleBlood advances2021

The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer.

Min Soon Cho, Jiasong Li, Ricardo Gonzalez-Delgado, Hani Lee, Matthew Vasquez, Tiancheng He, Yunjie He, Kai Liu, Tomoyuki Sasano, Bernd Nürnberg and 3 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target.Frontiers in cell and developmental biology · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Min Soon ChoSection of Benign Hematology, University of Texas MD Anderson Cancer Center, Houston, TX.
Jiasong LiDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Ricardo Gonzalez-DelgadoSection of Benign Hematology, University of Texas MD Anderson Cancer Center, Houston, TX.
Hani LeeSection of Benign Hematology, University of Texas MD Anderson Cancer Center, Houston, TX.
Matthew VasquezDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Tiancheng HeDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Yunjie HeDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Kai LiuDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Tomoyuki SasanoDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX; and.
Bernd NürnbergDepartment of Pharmacology, Experimental Therapy, and Toxicology, University of Tübingen, Tübingen, Germany.
Anil K SoodDepartment of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX; and.
Stephen T C WongDepartment of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Houston, TX.
Vahid Afshar-KharghanSection of Benign Hematology, University of Texas MD Anderson Cancer Center, Houston, TX.
Houston Methodist · USThe University of Texas MD Anderson Cancer Center · USUniversity of Tübingen · DE

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Targeting the PI3K Signaling Pathway in Endometrial CarcinomaP50CA098258 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BROADDUS, RUSSELL R · 2003 to 2020
$32.0M
U.T. M. D. Anderson Cancer Center SPORE in Ovarian CancerP50CA217685 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C, SOOD, ANIL K · 2017 to 2021
$7.9M
Platelets promote growth of ovarian cancerR01CA177909 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AFSHAR-KHARGHAN, VAHID, SOOD, ANIL K · 2013 to 2023
$4.1M
Genetics of Graft-versus-Host DiseaseR01CA231141 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AFSHAR-KHARGHAN, VAHID, GORLOVA, OLGA · 2018 to 2022
$1.6M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA098258NCI NIH HHS P50 CA217685NCI NIH HHS R01 CA177909NCI NIH HHS R01 CA231141
6 · The paper itself

Abstract

We and other investigators have shown that platelets promote metastasis and the growth of tumors. Our rationale for conducting this study is that platelets' prometastatic and progrowth effects depend on a close encounter between platelets and cancer cells. This interaction occurs inside blood vessels with circulating tumor cells and outside blood vessels with cancer cells residing in the tumor parenchyma. Our hypothesis was that platelet extravasation is required for the effect of platelets on tumor growth. Platelets respond to environmental stimuli by activation of G protein-coupled receptors on their surface. We investigated the impact of various platelet G proteins on the growth of ovarian cancer tumors and platelet extravasation. We used mice with platelet-specific deficiency of Gαi2 (Gi), Gα13 (G13), or Gαq (Gq) in a syngeneic ovarian cancer model. We measured the total weight of tumor nodules resected from tumor-bearing mice. We developed methods for automated whole-slide image acquisition and unbiased computerized image analysis to quantify extravasated platelets. We compared the number of platelets inside tumor nodules of platelet G protein-deficient tumor-bearing mice. We found that deficiency of Gi and G13, but not Gq, in platelets resulted in smaller tumors compared with those in corresponding littermates. Deficiency of Gi and G13 in platelets reduced the number of extravasated platelets by >90%, but deficiency of Gq did not reduce the number of extravasated platelets significantly. The lack of Gi or G13 in platelets reduced platelet extravasation into the tumor and tumor growth.

Indexed as

Blood PlateletsOvarian NeoplasmsAnimalsDisease Models, AnimalFemaleGTP-Binding ProteinsHumansMiceGTP-Binding Proteins

Identifiers

PMID33821990
PMCPMC8045495
OpenAlexW3145601915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.